Mayne Pharma Group Ltd has released a press release.
Mayne Pharma launches Amiodarone 200mg tablets in the US
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- Mayne Pharmas generic NuvaRing accepted for filing by FDA
- Mayne Pharma launches doxycycline IR capsules in the US
- First generic launch of Ritalin LA 10mg capsules in the US
- 2018 Half Year Investor Presentation
- 2018 Half Year Media Release
Later from Mayne Pharma
- Mayne Pharma opens new US manufacturing facility
- SUBA-Itraconazole NDA accepted for review by US FDA
- Mayne Pharma acquires generic Efudex in the US
- 2018 Full Year Results Media Release
- 2018 Full Year Results Investor Presentation
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma